SANA — SANA BIOTECHNOLOGY INC

Ownership history in SMITH, MOORE & CO.  ·  4 quarters on record

This page tracks every 13F SEC filing in which SMITH, MOORE & CO. reported a position in SANA BIOTECHNOLOGY INC (SANA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q2)
Avg. % of fund
0.0%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 11,250 -11,250 -50.0% 0.00% $40K $3.55
2025 Q2 UNCHANGED 22,500 — 0% 0.01% $61K $2.73
2025 Q1 ADDED 22,500 +12,500 +125.0% 0.00% $38K $1.68
2024 Q4 INITIATED 10,000 — — 0.00% $16K $1.63
% of Fund (quarterly)    SANA price (monthly, adj. close)

Other funds also holding SANA

As of 2025 Q4 — sorted by position size

Flagship Pioneering, LLC 3Y 7Y 31.4% Crestline Management, LP 3Y 7Y 9.32% Omega Fund Management, LLC 3Y 7Y 1.2% GREAT POINT PARTNERS LLC 3Y 7Y 0.92% Integral Health Asset Management, LLC 3Y 0.61% Alphabet Inc. 3Y 0.44% Palumbo Wealth Management LLC 3Y 0.12% ArrowMark Colorado Holdings LLC 3Y 7Y 0.06% Modus Advisors, LLC 3Y 0.06% Virtus Investment Advisers, LLC 3Y 7Y 0.06%
← Back to SMITH, MOORE & CO. Holdings